Side effects across medicines
Medicines whose labels list burning sensation
95 medicines have an FDA label that names burning sensation in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of burning sensation name estradiol (639), glatiramer (546) and potassium chloride (440), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list burning sensation?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of burning sensation |
|---|---|---|
| Tacrolimus | precautions (topical label) | 225 |
| Cromolyn | precautions | 34 |
| Cyclopentolate | precautions | none in the top 1,000 |
| Dextroamphetamine | warnings and precautions (transdermal label) | none in the top 1,000 |
| Idarubicin | precautions | none in the top 1,000 |
| Mesna | warnings and precautions (oral label) | none in the top 1,000 |
| Estradiol | adverse reactions | 639 |
| Glatiramer | adverse reactions | 546 |
| Potassium chloride | adverse reactions (intravenous label) | 440 |
| Sodium chloride | adverse reactions | 390 |
| Sumatriptan | adverse reactions (nasal label) | 290 |
| Gadobenate | adverse reactions | 272 |
| Lumateperone | adverse reactions | 216 |
| Mepolizumab | adverse reactions | 186 |
| Agalsidase beta | adverse reactions | 151 |
| Brimonidine | adverse reactions (topical label) | 125 |
| Desoximetasone | adverse reactions | 112 |
| Carbidopa and levodopa | adverse reactions | 109 |
| Gadobutrol | adverse reactions | 97 |
| Gadoterate | adverse reactions | 90 |
| Niacin | adverse reactions | 87 |
| Calcitriol | adverse reactions (topical label) | 82 |
| Human immunoglobulin g | adverse reactions | 81 |
| Ziconotide | adverse reactions | 67 |
| Clindamycin | adverse reactions (vaginal label) | 62 |
| Etodolac | adverse reactions | 34 |
| Tazarotene | adverse reactions (topical label) | 31 |
| Calcium chloride, icodextrin, magnesium chloride, sodium chloride and sodium lactate | adverse reactions | 30 |
| Paricalcitol | adverse reactions (intravenous label) | 29 |
| Silver sulfadiazine | adverse reactions | 28 |
| 68ga-dotatate | adverse reactions | none in the top 1,000 |
| Adapalene and benzoyl peroxide | adverse reactions | none in the top 1,000 |
| Alosetron | adverse reactions | none in the top 1,000 |
| Amoxicillin and omeprazole and rifabutin | adverse reactions | none in the top 1,000 |
| Anhydrous citric acid and gluconolactone and magnesium carbonate | adverse reactions | none in the top 1,000 |
| Articaine and epinephrine | adverse reactions | none in the top 1,000 |
| Becaplermin | adverse reactions | none in the top 1,000 |
| Benzoyl peroxide and erythromycin | adverse reactions | none in the top 1,000 |
| Betamethasone and calcipotriene | adverse reactions | none in the top 1,000 |
| Brigatinib | adverse reactions | none in the top 1,000 |
| Calcium chloride | adverse reactions | none in the top 1,000 |
| Carbidopa | adverse reactions | none in the top 1,000 |
| Carmustine | adverse reactions | none in the top 1,000 |
| Cefepime and zidebactam | adverse reactions | none in the top 1,000 |
| Cemiplimab | adverse reactions | none in the top 1,000 |
| Citric acid and lactic acid l- and potassium bitartrate | adverse reactions | none in the top 1,000 |
| Conestat alfa | adverse reactions | none in the top 1,000 |
| Crizotinib | adverse reactions | none in the top 1,000 |
| Daratumumab and hyaluronidase | adverse reactions | none in the top 1,000 |
| Desflurane | adverse reactions | none in the top 1,000 |
| Dextrose, magnesium chloride and 4 other ingredients | adverse reactions | none in the top 1,000 |
| Doxercalciferol | adverse reactions | none in the top 1,000 |
| Elranatamab | adverse reactions | none in the top 1,000 |
| Epinastine | adverse reactions | none in the top 1,000 |
| Epirubicin | adverse reactions | none in the top 1,000 |
| Glucarpidase | adverse reactions | none in the top 1,000 |
| Glutamine | adverse reactions | none in the top 1,000 |
| Glycerol phenylbutyrate | adverse reactions | none in the top 1,000 |
| Human albumin microspheres and perflutren | adverse reactions | none in the top 1,000 |
| Iomeprol | adverse reactions | none in the top 1,000 |
| Iopamidol | adverse reactions | none in the top 1,000 |
| Ivosidenib | adverse reactions | none in the top 1,000 |
| Ixabepilone | adverse reactions | none in the top 1,000 |
| Lidocaine and prilocaine | adverse reactions | none in the top 1,000 |
| Lidocaine and tetracaine | adverse reactions | none in the top 1,000 |
| Lorlatinib | adverse reactions | none in the top 1,000 |
| Mafenide | adverse reactions | none in the top 1,000 |
| Magnesium chloride, potassium chloride and 3 other ingredients | adverse reactions | none in the top 1,000 |
| Miconazole and petrolatum and zinc oxide | adverse reactions | none in the top 1,000 |
| Mitomycin | adverse reactions | none in the top 1,000 |
| Mosunetuzumab | adverse reactions | none in the top 1,000 |
| Motixafortide | adverse reactions | none in the top 1,000 |
| Naftifine | adverse reactions | none in the top 1,000 |
| Oteseconazole | adverse reactions | none in the top 1,000 |
| Patisiran | adverse reactions | none in the top 1,000 |
| Pegunigalsidase alfa | adverse reactions | none in the top 1,000 |
| Pexidartinib | adverse reactions | none in the top 1,000 |
| Pivekimab sunirine | adverse reactions | none in the top 1,000 |
| Porfimer | adverse reactions | none in the top 1,000 |
| Pretomanid | adverse reactions | none in the top 1,000 |
| Spinosad | adverse reactions | none in the top 1,000 |
| Tinidazole | adverse reactions | none in the top 1,000 |
| Tiopronin | adverse reactions | none in the top 1,000 |
| Tirbanibulin | adverse reactions | none in the top 1,000 |
| Tisotumab vedotin | adverse reactions | none in the top 1,000 |
| Tretinoin | trial table | 63 |
| Pomalidomide | patient leaflet | 174 |
| Clotrimazole | patient leaflet | 90 |
| Thalidomide | patient leaflet | 54 |
| Ivermectin | patient leaflet | 29 |
| Benzoyl peroxide and clindamycin | patient leaflet | none in the top 1,000 |
| Gemcitabine | patient leaflet | none in the top 1,000 |
| Nalmefene | patient leaflet | none in the top 1,000 |
| Naxitamab | patient leaflet | none in the top 1,000 |
| Telisotuzumab vedotin | patient leaflet | none in the top 1,000 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most burning sensation reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Burning Sensation”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch